nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.0284	0.0284	CcSEcCtD
Metaxalone—Haemolytic anaemia—Captopril—systemic scleroderma	0.0231	0.0231	CcSEcCtD
Metaxalone—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.0228	0.0228	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Captopril—systemic scleroderma	0.0215	0.0215	CcSEcCtD
Metaxalone—Drowsiness—Pentoxifylline—systemic scleroderma	0.0212	0.0212	CcSEcCtD
Metaxalone—Jaundice—Pentoxifylline—systemic scleroderma	0.0207	0.0207	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.0177	0.0177	CcSEcCtD
Metaxalone—Haemolytic anaemia—Lisinopril—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Metaxalone—Tension—Pentoxifylline—systemic scleroderma	0.0162	0.0162	CcSEcCtD
Metaxalone—Nervousness—Pentoxifylline—systemic scleroderma	0.0161	0.0161	CcSEcCtD
Metaxalone—Jaundice—Captopril—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.0152	0.0152	CcSEcCtD
Metaxalone—Abdominal discomfort—Azathioprine—systemic scleroderma	0.0151	0.0151	CcSEcCtD
Metaxalone—Leukopenia—Pentoxifylline—systemic scleroderma	0.0148	0.0148	CcSEcCtD
Metaxalone—Haemolytic anaemia—Mycophenolate mofetil—systemic scleroderma	0.0143	0.0143	CcSEcCtD
Metaxalone—Irritability—Lisinopril—systemic scleroderma	0.0141	0.0141	CcSEcCtD
Metaxalone—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Metaxalone—Jaundice—Leflunomide—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Metaxalone—Tension—Captopril—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Metaxalone—Jaundice—Mycophenolic acid—systemic scleroderma	0.0123	0.0123	CcSEcCtD
Metaxalone—Nervousness—Captopril—systemic scleroderma	0.0122	0.0122	CcSEcCtD
Metaxalone—Somnolence—Pentoxifylline—systemic scleroderma	0.012	0.012	CcSEcCtD
Metaxalone—Anaphylactic shock—Mometasone—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Metaxalone—Jaundice—Lisinopril—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Metaxalone—Anaphylactic shock—Captopril—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Metaxalone—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00996	0.00996	CcSEcCtD
Metaxalone—Leukopenia—Azathioprine—systemic scleroderma	0.0098	0.0098	CcSEcCtD
Metaxalone—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00971	0.00971	CcSEcCtD
Metaxalone—Tension—Mycophenolic acid—systemic scleroderma	0.00968	0.00968	CcSEcCtD
Metaxalone—Nervousness—Mycophenolic acid—systemic scleroderma	0.00958	0.00958	CcSEcCtD
Metaxalone—Pruritus—Pentoxifylline—systemic scleroderma	0.00956	0.00956	CcSEcCtD
Metaxalone—Leukopenia—Leflunomide—systemic scleroderma	0.00926	0.00926	CcSEcCtD
Metaxalone—Somnolence—Captopril—systemic scleroderma	0.00911	0.00911	CcSEcCtD
Metaxalone—Dizziness—Pentoxifylline—systemic scleroderma	0.00894	0.00894	CcSEcCtD
Metaxalone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00883	0.00883	CcSEcCtD
Metaxalone—Tension—Lisinopril—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Metaxalone—Nervousness—Lisinopril—systemic scleroderma	0.00863	0.00863	CcSEcCtD
Metaxalone—Vomiting—Pentoxifylline—systemic scleroderma	0.00859	0.00859	CcSEcCtD
Metaxalone—Rash—Pentoxifylline—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Metaxalone—Dermatitis—Pentoxifylline—systemic scleroderma	0.00851	0.00851	CcSEcCtD
Metaxalone—Headache—Pentoxifylline—systemic scleroderma	0.00847	0.00847	CcSEcCtD
Metaxalone—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00844	0.00844	CcSEcCtD
Metaxalone—Irritability—Prednisone—systemic scleroderma	0.00837	0.00837	CcSEcCtD
Metaxalone—Pruritus—Mometasone—systemic scleroderma	0.00825	0.00825	CcSEcCtD
Metaxalone—Nausea—Pentoxifylline—systemic scleroderma	0.00803	0.00803	CcSEcCtD
Metaxalone—Leukopenia—Lisinopril—systemic scleroderma	0.00796	0.00796	CcSEcCtD
Metaxalone—Tension—Mycophenolate mofetil—systemic scleroderma	0.00764	0.00764	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00757	0.00757	CcSEcCtD
Metaxalone—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00756	0.00756	CcSEcCtD
Metaxalone—Vomiting—Mometasone—systemic scleroderma	0.00741	0.00741	CcSEcCtD
Metaxalone—Rash—Mometasone—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Metaxalone—Dermatitis—Mometasone—systemic scleroderma	0.00735	0.00735	CcSEcCtD
Metaxalone—Headache—Mometasone—systemic scleroderma	0.00731	0.00731	CcSEcCtD
Metaxalone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Metaxalone—Pruritus—Captopril—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Metaxalone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Metaxalone—Irritability—Methotrexate—systemic scleroderma	0.00699	0.00699	CcSEcCtD
Metaxalone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00697	0.00697	CcSEcCtD
Metaxalone—Nausea—Mometasone—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Metaxalone—Dizziness—Captopril—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Metaxalone—Hypersensitivity—Azathioprine—systemic scleroderma	0.00659	0.00659	CcSEcCtD
Metaxalone—Vomiting—Captopril—systemic scleroderma	0.00651	0.00651	CcSEcCtD
Metaxalone—Rash—Captopril—systemic scleroderma	0.00646	0.00646	CcSEcCtD
Metaxalone—Dermatitis—Captopril—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Metaxalone—Somnolence—Lisinopril—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Metaxalone—Headache—Captopril—systemic scleroderma	0.00642	0.00642	CcSEcCtD
Metaxalone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Metaxalone—Hypersensitivity—Leflunomide—systemic scleroderma	0.00622	0.00622	CcSEcCtD
Metaxalone—Nausea—Captopril—systemic scleroderma	0.00608	0.00608	CcSEcCtD
Metaxalone—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Metaxalone—Pruritus—Leflunomide—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Metaxalone—Dizziness—Azathioprine—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Metaxalone—Pruritus—Mycophenolic acid—systemic scleroderma	0.0057	0.0057	CcSEcCtD
Metaxalone—Vomiting—Azathioprine—systemic scleroderma	0.00568	0.00568	CcSEcCtD
Metaxalone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00565	0.00565	CcSEcCtD
Metaxalone—Drowsiness—Methotrexate—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Metaxalone—Rash—Azathioprine—systemic scleroderma	0.00564	0.00564	CcSEcCtD
Metaxalone—Dermatitis—Azathioprine—systemic scleroderma	0.00563	0.00563	CcSEcCtD
Metaxalone—Headache—Azathioprine—systemic scleroderma	0.0056	0.0056	CcSEcCtD
Metaxalone—Dizziness—Leflunomide—systemic scleroderma	0.00558	0.00558	CcSEcCtD
Metaxalone—Vomiting—Leflunomide—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Metaxalone—Hypersensitivity—Lisinopril—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Metaxalone—Dizziness—Mycophenolic acid—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Metaxalone—Rash—Leflunomide—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Metaxalone—Dermatitis—Leflunomide—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Metaxalone—Nausea—Azathioprine—systemic scleroderma	0.00531	0.00531	CcSEcCtD
Metaxalone—Headache—Leflunomide—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Metaxalone—Pruritus—Lisinopril—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Metaxalone—Vomiting—Mycophenolic acid—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Metaxalone—Rash—Mycophenolic acid—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Metaxalone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00507	0.00507	CcSEcCtD
Metaxalone—Headache—Mycophenolic acid—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Metaxalone—Nausea—Leflunomide—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Metaxalone—Dizziness—Lisinopril—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Metaxalone—Nausea—Mycophenolic acid—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Metaxalone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00468	0.00468	CcSEcCtD
Metaxalone—Vomiting—Lisinopril—systemic scleroderma	0.00461	0.00461	CcSEcCtD
Metaxalone—Rash—Lisinopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Metaxalone—Dermatitis—Lisinopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Metaxalone—Headache—Lisinopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Metaxalone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0045	0.0045	CcSEcCtD
Metaxalone—Nausea—Lisinopril—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Metaxalone—Anaphylactic shock—Prednisone—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Metaxalone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Metaxalone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Metaxalone—Rash—Mycophenolate mofetil—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Metaxalone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.004	0.004	CcSEcCtD
Metaxalone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Metaxalone—Leukopenia—Methotrexate—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Metaxalone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Metaxalone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Metaxalone—Somnolence—Methotrexate—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Metaxalone—Hypersensitivity—Prednisone—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Metaxalone—Pruritus—Prednisone—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Metaxalone—Dizziness—Prednisone—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Metaxalone—Vomiting—Prednisone—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Metaxalone—Rash—Prednisone—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Metaxalone—Dermatitis—Prednisone—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Metaxalone—Headache—Prednisone—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Metaxalone—Hypersensitivity—Methotrexate—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Metaxalone—Nausea—Prednisone—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Metaxalone—Pruritus—Methotrexate—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Metaxalone—Dizziness—Methotrexate—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Metaxalone—Vomiting—Methotrexate—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Metaxalone—Rash—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Metaxalone—Dermatitis—Methotrexate—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Metaxalone—Headache—Methotrexate—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Metaxalone—Nausea—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
